Effects of Metabolically Healthy and Unhealthy Obesity on Prolongation of Corrected QT Interval

被引:13
|
作者
Guo, Xiaofan [1 ]
Li, Zhao [1 ]
Guo, Liang [1 ]
Yu, Shasha [1 ]
Yang, Hongmei [1 ]
Zheng, Liqiang [2 ]
Pan, Guowei [3 ]
Zhang, Yonghong [4 ]
Sun, Yingxian [1 ]
Pletcher, Mark J. [5 ]
机构
[1] China Med Univ, Hosp 1, Dept Cardiol, Shenyang, Liaoning, Peoples R China
[2] China Med Univ, Shengjing Hosp, Dept Clin Epidemiol, Shenyang, Liaoning, Peoples R China
[3] Inst Chron Dis, Liaoning Prov Ctr Dis Control & Prevent, Shenyang, Liaoning, Peoples R China
[4] Soochow Univ, Coll Med, Sch Publ Hlth, Dept Epidemiol, Suzhou, Jiangsu, Peoples R China
[5] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2017年 / 119卷 / 08期
关键词
RESTING HEART-RATE; CARDIOVASCULAR MORTALITY; NATIONAL-HEALTH; ALL-CAUSE; ASSOCIATION; POPULATION; PREDICTION; DISEASE; PHENOTYPE; DURATION;
D O I
10.1016/j.amjcard.2016.12.033
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although obesity and the metabolic syndrome (MS) often co-occur, many obese (OB) subjects have a favorable metabolic profile. It is unclear whether these factors independently influence cardiac electrophysiology including prolongation of the QT interval. We examined associations among obesity, MS, and prolonged corrected QT (QTc) interval in a large sample of Chinese research participants aged >= 35 years recruited from rural areas of Liaoning Province during 2012 to 2013. Of the 11,209 participants, 6,364 (56.8%) were nonobese and metabolically healthy (OB-/MS-), 2,853 (25.5%) were OB-/MS+, 493 (4.4%) were OB+/MS-, and 1,499 (13.4%) were OB +/MS+. Mean (+/- SD) QTc intervals were higher in OB-/MS+ (436.3 +/- 24.3) and OB +/MS+ (436.6 +/- 25.9) participants but not OB+/MS- participants (425.4 +/- 24.0) than in OB-/MS- participants (426.8 +/- 21.5, p <0.001), and the prevalence of QTc prolongation was higher in OB-/MS+ and OB+/MS+ participants (adjusted odds ratios [aOR] 1.68, 95% confidence interval [CI] 1.52 to 1.85; aOR 1.92, 95% CI 1.69 to 2.17, respectively) compared with OB-/MS- group but not in OB+/MS- participants (aOR 0.92, 95% CI 0.73 to 1.15). Prevalence increased with each MS component (aOR 1.27, 95% CI 1.22 to 1.32) but not with body mass index (aOR 1.01, 95% CI 0.99 to 1.02). In conclusion, prolonged QTc interval is associated with the MS and not independently associated with obesity. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:1199 / 1204
页数:6
相关论文
共 50 条
  • [41] Brain Alterations in Metabolically Unhealthy and Healthy Obesity Using a Quantitative Comparison
    Abazid, Leen
    [J]. OBESITY, 2023, 31 : 262 - 262
  • [42] Kidney function in minority children and adolescents with metabolically healthy and unhealthy obesity
    Arora, Sumeet
    Dunkley, Laura
    Waldman, Lee M.
    Chin, Vivian L.
    Umpaichitra, Vatcharapan
    [J]. CLINICAL OBESITY, 2020, 10 (01)
  • [43] Distinguishing health-related parameters between metabolically healthy and metabolically unhealthy obesity in women
    Mendonca, Fernando
    Soares, Pietra
    Moreno, Telma
    Freitas, Paula
    Rodrigues, Ilda
    Festas, Diana
    Pedro, Jorge
    Varela, Ana
    Fernandes, Ana
    Fernandes, Ruben
    Soares, Raquel
    Costa, Eduardo Lima
    Luis, Carla
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2024, 48 (07) : 1027 - 1035
  • [44] Differences in the Transcriptomic Profile of Visceral Fat in Persons With Metabolically "Healthy" versus Metabolically "Unhealthy" Obesity
    Meddeb, Mariam
    Wolf, Risa
    Wallace, Amelia S.
    Chu, Xin
    Florido, Roberta
    Tcheugui, Justin B. Echouffo
    Matsushita, Kuni
    Kass, David A.
    Gerstenblith, Gary
    Kim, Sangwon
    Ahima, Rexford
    Wood, G.
    Coresh, Josef
    Benotti, Peter
    Wong, G. William
    Ndumele, Chiadi E.
    [J]. CIRCULATION, 2022, 146
  • [45] The assessment of drug induced QT interval prolongation in healthy subjects:: QTc interval, QT (QTc) dispersion?
    Nemat, S
    Prasad, V
    Oliver, S
    Hedge, A
    Amakye, D
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 90 - 90
  • [46] Metabolically healthy obesity, transition from metabolic healthy to unhealthy status, and carotid atherosclerosis
    Huang, Qin
    Liu, Zeyu
    Wei, Minping
    Feng, Jie
    Huang, Qing
    Liu, Yunhai
    Liu, Zunjing
    Li, Xiaojun
    Yin, Li
    Xia, Jian
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2024, 40 (02)
  • [47] Corrected QT interval prolongation associated with intravenous haloperidol in acute coronary syndromes
    Douglas, PH
    Block, PC
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2000, 50 (03) : 352 - 355
  • [48] Frequency of Corrected QT (QTC) Interval Prolongation in Chronic Liver Disease Patients
    Qadir, Mehboob
    Chandia, Abdus Sattar
    Arif, Malik Muhammad
    Khan, Humayun Riaz
    Khans, Muhammad Shahid Nawaz
    Khaliq, Sheikh Abdul
    Irshad, Muzammil
    [J]. PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2019, 13 (03): : 537 - 538
  • [49] Corrected QT Interval Prolongation in Psychopharmacological Treatment and Its Modulation by Genetic Variation
    Corponi, Filippo
    Fabbri, Chiara
    Boriani, Giuseppe
    Diemberger, Igor
    Albani, Diego
    Forloni, Gianluigi
    Serretti, Alessandro
    [J]. NEUROPSYCHOBIOLOGY, 2018, 77 (02) : 67 - 72
  • [50] ASSOCIATION OF CORRECTED QT INTERVAL PROLONGATION WITH POLYPHARMACY IN PATIENTS WITH ADVANCED CANCER.
    Rowe, E.
    Shugg, T.
    Ly, R.
    Callaghan, J.
    Tisdale, J.
    Overholser, B.
    Philips, S.
    Radovich, M.
    Schneider, B.
    Skaar, T.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S67 - S67